Fig. 2From: Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxabanReceiver operating characteristics curves found for laboratory-based calibrated anti-Xa activity all four Hemochron™ Signature Elite point-of-care test system-based coagulation assays when testing for ruling out samples containing > 30 ng/mL (solid line) and > 50 ng/mL (dashed line)Back to article page